| Style | Citing Format |
|---|---|
| MLA | Hendijani F. "Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions." Cytotherapy, vol. 17, no. 5, 2015, pp. 509-525. |
| APA | Hendijani F (2015). Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions. Cytotherapy, 17(5), 509-525. |
| Chicago | Hendijani F. "Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions." Cytotherapy 17, no. 5 (2015): 509-525. |
| Harvard | Hendijani F (2015) 'Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions', Cytotherapy, 17(5), pp. 509-525. |
| Vancouver | Hendijani F. Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions. Cytotherapy. 2015;17(5):509-525. |
| BibTex | @article{ author = {Hendijani F}, title = {Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions}, journal = {Cytotherapy}, volume = {17}, number = {5}, pages = {509-525}, year = {2015} } |
| RIS | TY - JOUR AU - Hendijani F TI - Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions JO - Cytotherapy VL - 17 IS - 5 SP - 509 EP - 525 PY - 2015 ER - |